⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MREO News
Mereo BioPharma Group plc American Depositary Shares
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
prnewswire.com
MREO
Pomerantz LLP Informs Shareholders of Class Action Against Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
Pomerantz LLP Issues Important Reminder to Mereo BioPharma Group plc Shareholders – MREO
accessnewswire.com
MREO
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 Ready to Announce with Confidence?
newsfilecorp.com
MREO
MREO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Mereo BioPharma Group plc Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MREO
MREO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Mereo BioPharma Group plc Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MREO
Pomerantz LLP Notifies Investors of Class Action Against Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
Pomerantz LLP Issues Important Reminder to Mereo BioPharma Group plc Investors – MREO
accessnewswire.com
MREO
Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc.
globenewswire.com
POM
MREO
RARE
TCPC
Pomerantz LLP Issues Reminder to Shareholders in Mereo BioPharma Group plc of Class Action Lawsuit – MREO
accessnewswire.com
MREO